Table 3.
Adjusted ORs and 95%CIs of clinical variables on the risk of colorectal polyps, adenomatous polyps and hyperplastic polyps based on multinomial logistic regression
| Polyps | Model A | Model B | Model C |
| OR (95%CI) | OR (95%CI) | OR (95%CI) | |
| Colorectal polyps | |||
| NAFLD | 1.49 (1.26-1.76)b | 1.28 (1.07-1.52)a | 1.26 (1.05-1.51)a |
| Gender | 2.81 (2.37-3.34)b | 2.76 (2.32-3.29)b | |
| Age | 1.06 (1.05-1.06)b | 1.06 (1.05-1.06)b | |
| Smoking | 1.15 (0.98-1.35) | 1.15 (0.97-1.38) | |
| Alcohol | 1.01 (0.86-1.20) | ||
| MS | 1.12 (0.90-1.40) | ||
| Adenomatous polyps | |||
| NAFLD | 1.49 (1.18-1.87)a | 1.29 (1.02-1.64)a | 1.28 (1.01-1.64)a |
| Gender | 2.83 (2.22-3.61)b | 2.78 (2.18-3.55)b | |
| Age | 1.07 (1.06-1.08)b | 1.07 (1.06-1.08)b | |
| Smoking | 1.09 (0.88-1.36) | 1.06 (0.84-1.35) | |
| Alcohol | 1.09 (0.87-1.37) | ||
| MS | 1.02 (0.76-1.38) | ||
| Hyperplastic polyps | |||
| NAFLD | 1.73 (1.31-2.29)b | 1.40 (1.05-1.86)a | 1.35 (1.01-1.82)a |
| Gender | 3.23 (2.33-4.47)b | 3.12 (2.25-4.33)b | |
| Age | 1.03 (1.02-1.05)b | 1.03 (1.02-1.05)b | |
| Smoking | 1.30 (1.00-1.70)a | 1.27 (0.95-1.70) | |
| Alcohol | 1.09 (0.82-1.44) | ||
| MS | 1.13 (0.79-1.63) | ||
Model A is univariate analysis; Model B is adjusted for gender, age and smoking; Model C is adjusted for gender, age, smoking, alcohol and MS.
a
P < 0.05;
b
P < 0.001. NAFLD: Non-alcoholic fatty liver disease; MS: Metabolic syndrome.